ADVERTORIAL: PCSK9 inhibitors – Recognising innovation in cholesterol treatment to help address a UK health burden

Heart rate monitor

Increasing the use of PCSK9 inhibitors in patients with uncontrolled LDL-C supports national efforts to address one of the UK’s greatest health burdens.

You need to be an HSJ subscriber to read more


Subscribe to read the full article

With an HSJ subscription you’ll get access to:

  • Expert Briefing newsletters, covering nine topics and regions
  • Weekly Catch Up – a summary of the week’s most important stories
  • Unlimited access to
  • The HSJ app

Enquire about multi-user access